Envestnet Asset Management »

Miragen Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $464k 15k 31.12
2025-09-30 $284k 13k 21.58
2025-06-30 $187k 13k 13.98
2023-03-31 $214k 8.4k 25.44

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Core Msci Emkt (IEMG)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Envestnet Asset Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Fairmount Funds Management
VR Adviser
State Street Corporation
Deep Track Capital
Novo A/S
Geode Capital Management
Alliancebernstein
Tang Capital Management
Eversept Partners
Fisher Investments
Baker Bros. Advisors

View all funds holding Miragen Therapeutics